维普期刊资源整合服务平台（V6.5）

162篇 您的检索式：作者名="GIRAL P"

选中清除导出查看参考文献查看引证文献引用追踪共9页首页上一页第1页下一页末页 /9 跳转

	题名	作者	年代	出处	被引量
1	Mycophenolate mofetil does not modify the incidence of cytomegalovirus (CMV) disease after kidney transplantation but prevents CMV-induced chronic graft dysfunction显示文摘	Giral M Nguyen JM Daguin P	2001	J Am Soc Nephrol2001，12，：	1
2	Hepatitis C virus induced hypohetalipoproteinemia: a possible mechanism for steatosis in chronic hepatitis C显示文摘	Serfaty L Andreani T Giral P	2001	J Hepatol2001，，34：	1
3	Radial augmentation index is a surrogate marker of atherosclerotic burden in a primary farevention cohort 显示文摘	Rosenbaum D Giral P Chapman J	2013	Atherosclerosis2013，231，2：	1
4	Matrix metalloproteinases, inflammation and atherosclerosis : therapeutic perspectives 显示文摘	Beaudeux J L Giral P Bruckert E	2004	Clin Chem Lab Med2004，42，2：	1
5	Matrix metalloproteinases, inflammation and atherosclerosis : therapeutic perspectives 显示文摘	BEAUDEUX J L GIRAL P BRUCKERT E	2004	Clin Chern Lab Med2004，42，：	1
6	Rosiglitazone for nonalcoholic steatohepatitis : one - year results of the randomized placebo - controlled Fatty Liver Improvement with Rosiglitazone Therapy (FLIRT) Trial显示文摘	Ratziu V Giral P Jacqueminet S	2008	Gastroenterology2008，135，1：	1
7	Matrix metalloproteinases,inflammation and atherosclerosis:therapeutic perspectives显示文摘	Beaudeux J L Giral P Bruckert E	2004	Clin Chem Lab Med2004，42，2：	1
8	Role of blood pressure, uric acid, and hemorheological parameters on plasma homocyst(e) ine concentration显示文摘	Malinow MR Levenson J Giral P	1995	Atherosclerosis1995，114，2：	1
9	Factors associated with low compliance with lipid-lowering drugs in hyperlipidemic patient显示文摘	Kiorsis DN Giral P Bruckert E		0，，25：	1
10	Elevated C-reactive protein constitutes an independent predictor of advanced carotid plaques in dyslipidemic subjects显示文摘	Blackbum R Giral P Bruckert E		0，，12：	1
11	Matrix metallorapeutic perspectires显示文摘	Beaudeux J Giral P Bruclert E	2004	Clin Chem Lab Med2004，42，2：	1
12	Fibrinogen and silent atherosclerosis in subjects with cardiovascular risk factors 显示文摘	Giral P Razavian M	1995	Arterioscler Thromb Vasc Biol1995，15，：	1
13	Risk factors and early extracoronary atheroselerotic plaque detected by three side ultrasound imaging in hypercholesterolemic men 显示文摘	Giral P Pithois Merli I Filitti V	1991	Arch Intern Med1991，151，13：	1
14	Resveratrol: a relevant pharmacological approach for the treatment of metabolic syndrome显示文摘	Beaudeux JL Nivet-Antoine V Giral P	2010	Curr Opin Clin Nutr Metab Care2010，13，6：	1
15	Cysteine Is a Cardiovascular Risk Factor in Hyperlipidemic Patients 显示文摘	JACOB N BRUCKERT E GIRAL P	1999	Atherosclerosis1999，146，：	1
16	Fibrinogen and its relations to subclinical extrocoronary and coronary ateriosclerosis in hypercholesterolemic men显示文摘	Levenson J Giral P	1997	Arterioscler Thromb Vasc Biol1997，17，：	1
17	Relation between plasminogen activator inhibitor-1 and hepatic enzyme concentrations in hyperlipidemic patients 显示文摘	Bruckert E Ankri A Giral P	1994	Thromb Haemost1994，72，3：	1
18	Matrix metalloproteinases, inflammation and atherosclerosis :therapeutic perspectives显示文摘	Beandeux JL Giral P Bruckert E	2004	Clin Chem Lab Med2004，42，2：	1
19	Usefulness in predicting coronary artery disease by ultrasonic evaluation of carotid arteries in asymptomatic hypercholesterolemic patients with positive exercise st ress tests显示文摘	Giral P Bruckert E Dairou F	1999	Am J Cardiol1999，84，1：	1
20	Fibrinogen and silent atherosclerosis in subject swith cardiovascular risk factors 显示文摘	LEVERSON J GIRAL P RAZVIAN M	1995	Arterioscler Thfromb Vasc Biol1995，15，10：	1

返回顶部每页显示：

共9页首页上一页第1页下一页末页 /9 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示